e-ISSN: Pending
Negative / Null Result ReportOpen accessDiseases of the genitourinary system. Urology

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection

Eric V. Li; Sai K. Kumar; Jonathan A. Aguiar; Mohammad R. Siddiqui; Clayton Neill; Zequn Sun; Edward M. Schaeffer; Anugayathri Jawahar · 2024 · BJUI Compass

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Abstract Objective This study aimed to evaluate the association of dynamic contrast enhancement (DCE) with clinically significant prostate cancer (csPCa, Gleason Grade Group ≥2) and compare biparametric magnetic resonance imaging (bpMRI) and multiparametric MRI (mpMRI) nomograms. Subjects/patients and methods We identified a retrospective cohort of biopsy naïve patients who underwent pre‐biopsy MRI separated by individual MRI series from 2018 to 2022. csPCa detection rates were calculated for patients with peripheral zone (PZ) lesions scored 3–5 on diffusion weighted imaging (DWI) with availab

Abstract by Eric V. Li; Sai K. Kumar; Jonathan A. Aguiar; Mohammad R. Siddiqui; Clayton Neill; Zequn Sun; Edward M. Schaeffer; Anugayathri Jawahar, BJUI Compass (2024) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1002/bco2.415